Single-dose, Study of RBP-6000 in Opioid Dependent Individuals

NCT02765867 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

18

Enrollment

INDUSTRY

Sponsor class

Conditions

Opioid Use Disorder

Interventions

DRUG: RBP-6000

Sponsor

Indivior Inc.